Where the numbers come from
Every number here is copied from section 14 of the current US Zepbound prescribing information. For each dose it takes the average weight lost, the share of people who lost at least 5, 10, 15 and 20%, and the placebo group, and multiplies your weight by them. The label counts everyone who started the trial, whether or not they kept taking it. Some websites quote bigger numbers from a second analysis that only counts people who stayed on the medicine, and some mix the two; we don’t.
| Zepbound dose | Trial | Average loss | On placebo | Lost 20% or more |
|---|---|---|---|---|
| 5 mg | SURMOUNT-1, 72 weeks | 15.0% | 3.1% | 30.0 in 100 |
| 10 mg | SURMOUNT-1, 72 weeks | 19.5% | 3.1% | 50.1 in 100 |
| 15 mg | SURMOUNT-1, 72 weeks | 20.9% | 3.1% | 56.7 in 100 |
| 10 mg, type 2 diabetes | SURMOUNT-2, 72 weeks | 12.8% | 3.2% | 21.5 in 100 |
| 15 mg, type 2 diabetes | SURMOUNT-2, 72 weeks | 14.7% | 3.2% | 30.8 in 100 |
Zepbound and Mounjaro
Zepbound and Mounjaro are both tirzepatide, made by Lilly, at the same doses. In the US, Zepbound’s label covers weight management and Mounjaro’s covers type 2 diabetes, which is why this calculator uses Zepbound’s trials. In the UK and EU, Mounjaro is also authorised for weight management, and the same SURMOUNT trials apply.
The dose steps come first
Everyone starts at 2.5 mg and steps up by 2.5 mg no sooner than every four weeks. The trial groups reached 5 mg in week 5, 10 mg in week 13 and 15 mg in week 21, then stayed there. So the scale often moves slowly in the first two months. The Zepbound dosage chart shows every step.
The label reports weight at the end of the trial, not week by week, so this calculator doesn’t draw a curve. One marker: in SURMOUNT-4, people had lost 20.9% after 36 weeks on the highest dose they could tolerate (Aronne et al., JAMA 2024).
Is your goal realistic on Zepbound?
The calculator compares your goal with how many people in the trial reached it. On 15 mg, 83.5 in 100 lost at least 10% and 56.7 in 100 lost 20% or more; on 5 mg, those numbers were 68.5 and 30.0. If you don’t have a goal yet, the ideal weight calculator shows the healthy BMI range for your height and 5, 10 and 15% steps on the way.
Staying on it
In SURMOUNT-4, people who switched to placebo regained 14.0% of their weight over the next year, while those who stayed on lost another 5.5% (Aronne et al., JAMA 2024). The label describes Zepbound as a treatment for chronic weight management. To compare with semaglutide, see the Wegovy weight loss calculator or the GLP-1 weight loss calculator.
Track it against the trial
In Mingo you log each Zepbound or Mounjaro dose and every weigh-in on one chart that marks each dose change, so you can see how your own numbers compare with the trial and show your doctor.





